The stock's fall snapped a three-day winning streak.

What Happened? Shares of biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) fell 3.5% in the afternoon session after a ...

This was the stock's third consecutive day of gains.

Anal cancer is a rare yet increasing cancer linked primarily to high-risk HPV strains such as HPV-16 and HPV-18. Key risk factors include weakened immune systems, age over 50, and high-risk sexual ...

Bristol Myers Squibb is undervalued despite challenges. Learn how BMY stock's strong pipeline, cash flow, and growth ...

Bristol Myers Squibb outperformed major indexes, closing 1.32% higher at $47.66, while peers lagged. The company’s stock ...

Skadden partner Joseph Barloon, former Jones Day partner Brett Shumate and former Wilmer partner Jeffrey Kessler, among ...

AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio.

Bristol-Myers Squibb stock saw a modest bump to $47.55 despite analysts waving caution flags. Short- and long-term technical ...

Shares of top US drugmakers Pfizer, Merck, Eli Lilly, Bristol Myers and Johnson & Johnson all dipped during the cabinet ...

A gas fire “of uncertain origin” caused the June 29 explosion that killed one person, hospitalized two others and displaced ...